ENTPD1, IL17A, and P2RX7 were downregulated, while HSP90AA1, PIK3CA, and NT5E were upregulated, indicating that ENTPD1, IL17A, and P2RX7 might negatively affect tumor development and result in better outcome. The gene discussed is NT5E; the disease is neoplasm.